Case report: Long-term survival in a patient with metastatic colorectal cancer treated with trifluridine/tipiracil in the third-line setting

Third-line treatment with trifluridine/tipiracil (FTD/TPI) is recommended for patients with metastatic colorectal cancer (mCRC) or gastric/gastroesophageal cancer (GC) who have progressed beyond first- and second-line therapy. We describe a patient with long-term survival following treatment with FT...

Descripción completa

Detalles Bibliográficos
Autor principal: ELBassiouny, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019825/
https://www.ncbi.nlm.nih.gov/pubmed/36937418
http://dx.doi.org/10.3389/fonc.2023.1112224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019825/
https://www.ncbi.nlm.nih.gov/pubmed/36937418
http://dx.doi.org/10.3389/fonc.2023.1112224

Ejemplares similares